Rep. Miller-Meeks voted yes on 8 of 8 bills (100%) classified as favoring her top donor sectors including Pharmaceuticals & Biotech and Securities & Investment, ranking 35th highest among House members. She voted yes on HR3537-117, the Accelerating Access to Critical Therapies for ALS Act, classified as favoring pharmaceuticals, and voted yes on 4 of 5 bills classified as limiting those same sectors.

EXAMPLE VOTES BEHIND THE NUMBER
HR3537-117 — Accelerating Access to Critical Therapies for ALS Act
HR8454-117 — Medical Marijuana and Cannabidiol Research Expansion Act
HJRES25-119 — Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule
FOLLOW THE TRAIL
◈ Ask the Analyst about Mariannette Miller-Meeks →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated September 7, 2026 · internal signal score 90/100.